Skip to main content
Fig. 4 | BMC Anesthesiology

Fig. 4

From: Increased circulating microRNA-122 is associated with mortality and acute liver injury in the acute respiratory distress syndrome

Fig. 4

Thirty-day survival in patients with the acute respiratory distress syndrome (ARDS) stratified for relative miR-122 expression (2-ΔCT) in a relative expression rate in serum ≤0.01 and > 0.01. Kaplan-Meier estimates were used to calculate probabilities of 30-day survival. Thirty-day survival was 83% in patients with a 2-ΔCT ≤ 0.01 but only 41%in patients with a relative miR-122 expression of 2-ΔCT > 0.01 (p < 0.001)

Back to article page